Pregnant women living with HIV (WLH) supported at clinics by peer WLH: a cluster randomized controlled trial

Linda Richter, Mary Jane Rotheram-Borus, Alastair Van Heerden, Alan Stein, Mark Tomlinson, Jessica M Harwood, Tamsen Rochat, Heidi Van Rooyen, W Scott Comulada, Zihling Tang, Linda Richter, Mary Jane Rotheram-Borus, Alastair Van Heerden, Alan Stein, Mark Tomlinson, Jessica M Harwood, Tamsen Rochat, Heidi Van Rooyen, W Scott Comulada, Zihling Tang

Abstract

Throughout Africa, Peer Mentors who are women living with HIV (WLH) are supporting pregnant WLH at antenatal and primary healthcare clinics (McColl in BMJ 344:e1590, 2012). We evaluate a program using this intervention strategy at 1.5 months post-birth. In a cluster randomized controlled trial in KwaZulu-Natal, South Africa, eight clinics were randomized for their WLH to receive either: standard care (SC), based on national guidelines to prevent mother-to-child transmission (4 clinics; n = 656 WLH); or an enhanced intervention (EI; 4 clinics; n = 544 WLH). The EI consisted of four antenatal and four postnatal small group sessions led by Peer Mentors, in addition to SC. WLH were recruited during pregnancy and 70 % were reassessed at 1.5 months post-birth. EI's effect was ascertained on 16 measures of maternal and infant well-being using random effects regressions to control for clinic clustering. A binomial test for correlated outcomes evaluated EI's overall effectiveness. Among EI WLH reassessed, 87 % attended at least one intervention session (mean 4.1, SD 2.0). Significant overall benefits were found in EI compared to SC using the binomial test. However, it is important to note that EI WLH were significantly less likely to adhere to ARV during pregnancy compared to SC. Secondarily, compared to SC, EI WLH were more likely to ask partners to test for HIV, better protected their infants from HIV transmission, and were less likely to have depressed mood and stunted infants. Adherence to clinic intervention groups was low, yet, there were benefits for maternal and infant health at 1.5 months post-birth.

Trial registration: ClinicalTrials.gov NCT00972699.

Figures

Fig. 1
Fig. 1
Movement of participants through the trial at each assessment point for mothers in the standard care (SC) and the enhanced intervention (EI). 1Among mothers reassessed post-birth
Fig. 2
Fig. 2
Adherence to cumulative behaviours in the PMTCT cascade among participants at 1.5 months post-birth (N = 843), grouped by intervention condition: Enhanced Intervention (EI, N = 377) versus Standard Care (SC, N = 466). Key: A Maternal AZT from the 28th week of pregnancy, or on HAART. B Maternal AZT during labour, or on HAART. C Maternal NVP at onset of labour, or on HAART. D Infant NVP within 24 h of birth. E Infant AZT dispensed and medicated as prescribed. F One feeding method first week post-birth. Note: “+” indicates that the behaviour listed includes itself and all behaviours listed to the left: cumulative adherence. EI and SC compared using random effects logistic regression, adjusting for clinic clustering. A*: OR EI versus SC (95 % CI) = 0.44 (0.26, 0.74), p = 0.002; E: OR = 1.72 (1.04, 2.86), p = 0.036; F: OR = 1.72 (1.08, 2.75), p = 0.023

Source: PubMed

3
Subscribe